Nicholson Nur 4

Accession 0001492422-26-000056

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:08 PM ET

Size

4.5 KB

Accession

0001492422-26-000056

Research Summary

AI-generated summary of this filing

Updated Jan 23, 2026

Apellis (APLS) CTO Nicholson Nur Sells 7,725 Shares

What Happened
Nicholson Nur, Chief Technical Officer of Apellis Pharmaceuticals (APLS), sold 7,725 shares on January 22, 2026 at $21.77 per share, generating proceeds of $168,138. The Form 4 reports this transaction as a sale (S) and the filing notes the shares were sold to cover tax withholding on Restricted Stock Units that vested on January 21, 2026.

Key Details

Transaction date and price: 2026-01-22 — 7,725 shares @ $21.77 per share.
Total proceeds: $168,138 (gross).
Reason given (footnote F1): Shares sold to cover tax withholding on RSUs released Jan 21, 2026.
Filing date / timeliness: Report filed 2026-01-23 (filed the next day; within the Form 4 reporting window).
Shares owned after transaction: Not specified in the provided filing excerpt.

Context
This was a tax-withholding sale tied to RSU vesting, a common and typically routine transaction for executives and not necessarily a signal about the insider's view of the company. Purchases or large, unscheduled sales can be more informative about insider sentiment; this transaction appears administrative in nature.